14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.0060 $169.56 Wednesday, 8th May 2024 ACRS stock ended at $1.22. This is 8.96% less than the trading day before Tuesday, 7th May 2024. During the day the stock fluctuated 12.29% from a day low at $1.20 to a day high of $1.35.
90 days $113.65 $133.77
52 weeks $171.20 $133.77

Historical Aclaris Therapeutics prices

Date Open High Low Close Volume
Dec 30, 2016 $26.99 $27.38 $26.75 $27.14 138 009
Dec 29, 2016 $27.40 $27.78 $26.59 $27.10 141 951
Dec 28, 2016 $27.65 $27.78 $27.18 $27.40 128 559
Dec 27, 2016 $28.20 $28.39 $27.57 $27.62 142 493
Dec 23, 2016 $28.11 $28.54 $27.65 $28.21 226 710
Dec 22, 2016 $29.79 $29.81 $27.84 $28.08 116 147
Dec 21, 2016 $30.29 $30.74 $29.66 $29.81 132 716
Dec 20, 2016 $30.80 $31.41 $30.09 $30.29 136 408
Dec 19, 2016 $31.68 $31.80 $30.53 $30.77 232 551
Dec 16, 2016 $29.02 $31.44 $28.82 $31.25 494 184
Dec 15, 2016 $28.43 $29.23 $27.78 $28.92 190 296
Dec 14, 2016 $28.30 $29.59 $27.52 $28.50 138 998
Dec 13, 2016 $29.02 $29.12 $28.31 $28.45 106 762
Dec 12, 2016 $29.09 $29.32 $28.49 $28.82 109 742
Dec 09, 2016 $28.83 $30.34 $27.66 $29.28 286 261
Dec 08, 2016 $29.72 $29.76 $28.30 $28.97 166 283
Dec 07, 2016 $29.55 $30.28 $29.03 $29.80 95 608
Dec 06, 2016 $30.10 $30.76 $29.62 $30.55 140 478
Dec 05, 2016 $29.81 $30.24 $28.94 $30.15 121 543
Dec 02, 2016 $29.04 $29.98 $28.35 $29.47 184 440
Dec 01, 2016 $29.78 $30.63 $28.36 $29.01 451 815
Nov 30, 2016 $30.33 $30.33 $29.12 $29.95 296 850
Nov 29, 2016 $29.00 $30.44 $28.50 $30.14 664 649
Nov 28, 2016 $27.91 $28.31 $27.27 $28.04 230 670
Nov 25, 2016 $28.05 $28.77 $27.40 $27.73 271 263
Click to get the best stock tips daily for free!

About Aclaris Therapeutics

Aclaris Therapeutics Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant unmet needs for immuno-inflammatory diseases. The Contract Research segment engages in the provision of... ACRS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT